Effects of Water and Glucose Drinks on Cardiovascular Function in Subjects With and Without Postprandial Hypotension
Primary Purpose
Autonomic Nervous System Diseases, Baroreflex Failure, Blood Pressure
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Glucose
Water
Sponsored by
About this trial
This is an interventional basic science trial for Autonomic Nervous System Diseases
Eligibility Criteria
Inclusion Criteria:
- Control subjects: subjects from this group will be healthy, with normal BMI. PPH subjects: Patients who have been diagnosed with PPH (defined as a fall in systolic blood pressure (BP) of > 20mmHg within 2 hours of a meal).
Exclusion Criteria:
- No history of severe respiratory, cardiovascular, hepatic and/or renal disease, diabetes, are not taking any medication with effects on blood pressure or gastrointestinal function, have not donated blood for the past 12 weeks or been involved in any research projects for the past 3 months.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Glucose
Control
Arm Description
75g glucose and 150mg C13-acetate in 300ml water
300ml water
Outcomes
Primary Outcome Measures
Change from baseline systolic blood pressure over time.
time= 0 min is defined as the consumption of either the experimental or control drink, i.e. outcome will be assessed for 2 hours.
Secondary Outcome Measures
Change from baseline cardiac output as assessed by echocardiography, over time.
time= 0 min is defined as the consumption of either the experimental or control drink, i.e. outcome will be assessed for 2 hours.
Change from baseline stroke volume as assessed by echocardiography, over time.
time= 0 min is defined as the consumption of either the experimental or control drink, i.e. outcome will be assessed for 2 hours.
Change from baseline ejection fraction as assessed by echocardiography, over time.
time= 0 min is defined as the consumption of either the experimental or control drink, i.e. outcome will be assessed for 2 hours.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02713412
Brief Title
Effects of Water and Glucose Drinks on Cardiovascular Function in Subjects With and Without Postprandial Hypotension
Official Title
Cardiovascular Function and Postprandial Hypotension (PPH): Effect of an Oral Glucose Load on Cardiac Contractility, Cardiac Output, Diastolic Function and Endothelial Function - Relationship to Gastric Emptying
Study Type
Interventional
2. Study Status
Record Verification Date
March 2016
Overall Recruitment Status
Completed
Study Start Date
April 2013 (undefined)
Primary Completion Date
October 2014 (Actual)
Study Completion Date
October 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Royal Adelaide Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
To determine whether the changes in blood pressure (BP) which occur following meals in normal people and patients who have substantial falls in BP after a meal postprandial hypotension (PPH)) are associated with changes in cardiac function. Eligible subjects who have been previously diagnosed with PPH will report to the Queen Elizabeth Hospital, on two occasions, following an overnight fast. Subjects will be cannulated and have a BP cuff placed around their upper arm. Following this, subjects will ingest either a drink containing 75 grams of glucose and 150mg of a C13 Acetate (which is metabolised and excreted in the breath, enabling noninvasive measurements of gastric emptying), made up to 300mL water, or on the other study day, 300mL water alone. The order of the study days will be randomised. Following the drink, for 3 hours, measurements will be taken at regular intervals of BP, heart rate, breath samples (on the study day with the Acetate only), blood samples (for measurement of blood glucose and gut hormones) and transthoracic echocardiography (TTE) (for assessment of end systolic and diastolic cardiac volume, cardiac output, cardiac contractility and diastolic function). After the 3 hours of measurements, the cannula will be removed and subjects will be offered lunch prior to leaving the department. Following lunch, on one study day, subjects will have their autonomic nerve function tested noninvasively, using an ECG.
Detailed Description
Subjects who meet the inclusion criteria will be required to attend the Queen Elizabeth Hospital, on two separate occasions, at 08:30h following an overnight fast (solids for 14 hours and liquids for 12 hours) and abstaining from smoking for 12 hours prior to the study day. The order of the study days will be randomized using the online Random Integer Set Generator program (RANDOM.ORG).
On each of the study days, subjects will be seated and have an intravenous cannula inserted into an antecubital vein in the arm for blood sampling and an automated blood pressure (BP) cuff (DINAMAP ProCare 100, GE Medical Systems, Milwaukee, WI, USA) placed around the opposite arm for measurements of BP (systolic and diastolic) and heart rate (HR).
After a 15-minute rest period, subjects will consume a drink consisting of either 75g glucose and 150 mg of 13C-acetate made up to 300 ml with water, or 300 ml water, within 3 minutes (t = -3 - 0 minutes).
BP and HR will be measured at 3 minute intervals during the 30-minute rest period prior to the drink (i.e. t = -30 - 0 minutes) and at 3 minute intervals from t = 0 - 180 minutes.
Blood samples (~ 18ml) will be taken prior (t = -3 minutes) to the drink and then at t = 30, 60, 90, 120 and 180 minutes for the subsequent measurement of blood glucose, serum insulin and incretin hormones. Samples will be stored at -70°C until analysed. Blood glucose will be determined immediately using a portable glucometer (Medisense Companion 2 meter, Medisense Inc, Waltham, USA).
Following the 75g drink consisting of 75g glucose and 150 mg of 13C-acetate made up to 300 ml with water, at t = -3 minutes, and every 5 minutes between t = 0 - 60, followed by every 15 minutes between t = 60 - 180, breath samples will be collected in sealed tubes for subsequent analysis of 13CO2 for measurement of gastric emptying.
At t = -30 minutes and then at t = 30, 60, 90, 120 and 180 minutes, subjects will also undergo Transthoracic Echocardiogram (TTE) for assessment of (i) end-systolic and diastolic volumes (ii) cardiac output (iii) cardiac contractility, as assessed by measuring
left ventricular dP/dt and
overall wall motion by Doppler tissue imaging (DTI) of basal mitochondrial segments (iv) diastolic function, as assessed by measuring
a) mitral inflow velocities b) DTI of mitral annulus c) left atrial size and d) pulmonary vein flow patterns Prior to each measurement, subjects will be allowed to rest for 15 minutes, remaining still in a supine position.
At t = 180 the cannulae will be removed and subjects will be offered a light lunch before leaving the department. The total amount of blood collected during the two visits is ~180 ml.
On one of the study days after completion of these measurements autonomic nerve function will be assessed using standardised cardiovascular reflex tests. Parasympathetic function will be calculated by the variation (R - R interval) of the HR during deep breathing and the immediate HR response to standing ("30:15" ratio). Sympathetic function will be assessed by the fall in systolic BP in response to standing.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Autonomic Nervous System Diseases, Baroreflex Failure, Blood Pressure, Hypotension
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
8 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Glucose
Arm Type
Experimental
Arm Description
75g glucose and 150mg C13-acetate in 300ml water
Arm Title
Control
Arm Type
Placebo Comparator
Arm Description
300ml water
Intervention Type
Other
Intervention Name(s)
Glucose
Intervention Description
75g glucose and 150 mg of 13C-acetate made up to 300 ml with water
Intervention Type
Other
Intervention Name(s)
Water
Intervention Description
300ml water
Primary Outcome Measure Information:
Title
Change from baseline systolic blood pressure over time.
Description
time= 0 min is defined as the consumption of either the experimental or control drink, i.e. outcome will be assessed for 2 hours.
Time Frame
time= 0 - 120 min
Secondary Outcome Measure Information:
Title
Change from baseline cardiac output as assessed by echocardiography, over time.
Description
time= 0 min is defined as the consumption of either the experimental or control drink, i.e. outcome will be assessed for 2 hours.
Time Frame
time= 0 - 120 min
Title
Change from baseline stroke volume as assessed by echocardiography, over time.
Description
time= 0 min is defined as the consumption of either the experimental or control drink, i.e. outcome will be assessed for 2 hours.
Time Frame
time= 0 - 120 min
Title
Change from baseline ejection fraction as assessed by echocardiography, over time.
Description
time= 0 min is defined as the consumption of either the experimental or control drink, i.e. outcome will be assessed for 2 hours.
Time Frame
time= 0 - 120 min
10. Eligibility
Sex
All
Minimum Age & Unit of Time
65 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Control subjects: subjects from this group will be healthy, with normal BMI. PPH subjects: Patients who have been diagnosed with PPH (defined as a fall in systolic blood pressure (BP) of > 20mmHg within 2 hours of a meal).
Exclusion Criteria:
No history of severe respiratory, cardiovascular, hepatic and/or renal disease, diabetes, are not taking any medication with effects on blood pressure or gastrointestinal function, have not donated blood for the past 12 weeks or been involved in any research projects for the past 3 months.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Karen L Jones, PhD
Organizational Affiliation
karen.jones@adelaide.edu.au
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Anonymous study data (minus all demographic data which compromises confidentiality) will be made available in a publicly accessible depository after publication.
Citations:
PubMed Identifier
19553500
Citation
Gentilcore D, Nair NS, Vanis L, Rayner CK, Meyer JH, Hausken T, Horowitz M, Jones KL. Comparative effects of oral and intraduodenal glucose on blood pressure, heart rate, and splanchnic blood flow in healthy older subjects. Am J Physiol Regul Integr Comp Physiol. 2009 Sep;297(3):R716-22. doi: 10.1152/ajpregu.00215.2009. Epub 2009 Jun 24.
Results Reference
background
PubMed Identifier
9505868
Citation
Jones KL, Tonkin A, Horowitz M, Wishart JM, Carney BI, Guha S, Green L. Rate of gastric emptying is a determinant of postprandial hypotension in non-insulin-dependent diabetes mellitus. Clin Sci (Lond). 1998 Jan;94(1):65-70. doi: 10.1042/cs0940065.
Results Reference
background
PubMed Identifier
11956353
Citation
O'Donovan D, Feinle C, Tonkin A, Horowitz M, Jones KL. Postprandial hypotension in response to duodenal glucose delivery in healthy older subjects. J Physiol. 2002 Apr 15;540(Pt 2):673-9. doi: 10.1113/jphysiol.2001.013442.
Results Reference
background
PubMed Identifier
21942924
Citation
Trahair LG, Vanis L, Gentilcore D, Lange K, Rayner CK, Horowitz M, Jones KL. Effects of variations in duodenal glucose load on blood pressure, heart rate, superior mesenteric artery blood flow and plasma noradrenaline in healthy young and older subjects. Clin Sci (Lond). 2012 Mar;122(6):271-9. doi: 10.1042/CS20110270.
Results Reference
background
PubMed Identifier
20554933
Citation
Vanis L, Gentilcore D, Hausken T, Pilichiewicz AN, Lange K, Rayner CK, Feinle-Bisset C, Meyer JH, Horowitz M, Jones KL. Effects of gastric distension on blood pressure and superior mesenteric artery blood flow responses to intraduodenal glucose in healthy older subjects. Am J Physiol Regul Integr Comp Physiol. 2010 Sep;299(3):R960-7. doi: 10.1152/ajpregu.00235.2010. Epub 2010 Jun 16.
Results Reference
background
PubMed Identifier
7698571
Citation
Braden B, Adams S, Duan LP, Orth KH, Maul FD, Lembcke B, Hor G, Caspary WF. The [13C]acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals. Gastroenterology. 1995 Apr;108(4):1048-55. doi: 10.1016/0016-5085(95)90202-3.
Results Reference
background
PubMed Identifier
14600930
Citation
Chew CG, Bartholomeusz FD, Bellon M, Chatterton BE. Simultaneous 13C/14C dual isotope breath test measurement of gastric emptying of solid and liquid in normal subjects and patients: comparison with scintigraphy. Nucl Med Rev Cent East Eur. 2003;6(1):29-33.
Results Reference
background
PubMed Identifier
7995201
Citation
Mossi S, Meyer-Wyss B, Beglinger C, Schwizer W, Fried M, Ajami A, Brignoli R. Gastric emptying of liquid meals measured noninvasively in humans with [13C]acetate breath test. Dig Dis Sci. 1994 Dec;39(12 Suppl):107S-109S. doi: 10.1007/BF02300386.
Results Reference
background
PubMed Identifier
1893685
Citation
Piha SJ. Cardiovascular autonomic reflex tests: normal responses and age-related reference values. Clin Physiol. 1991 May;11(3):277-90. doi: 10.1111/j.1475-097x.1991.tb00459.x.
Results Reference
background
Learn more about this trial
Effects of Water and Glucose Drinks on Cardiovascular Function in Subjects With and Without Postprandial Hypotension
We'll reach out to this number within 24 hrs